Aging Patients_Immune Activation in Elderly People Living with HIV - Peter Hunt

APACC 2022

Recent Advances in the Treatment of Tuberculosis_Shorter Regimens for Drug-Susceptible and Resistant TB - Nicholas Paton

COVID-19 in People Living with HIV_Social Inequality and COVID-19 - Adeeba Kamarulzaman

Neuro Cognitive Complications of Aging - The Social Perspective - Andrew Tan Tze Tho

APACC 2022

Neuro Cognitive Complications of Aging - The Clinical Perspective - Grace Chung-Yan Lui

Systematic Review and Crowdfunding Practical Guide - Eneyi Kpokiri

Harnessing Online and Offline Methods for Crowdfunding in Thailand - Teerawat Wiwatpanit

What Makes a Successful Online Campaign - Rayner Kay Jin Tan

Implementation of PrEP - Vietnam's Experience with Self-Testing - Hong Anh Doan

Differentiated & Simplified PrEP for HIV Prevention - Heather-Marie Schmidt

APACC 2022

Donor & Implementer Perspective - Pimpanitta Saenyakul

Global Perspective - Meg Doherty

New Antiretroviral Drugs-Formulations for the Treatment of PLWH and for Prevention of HIV - Jennifer Hoy

APACC 2022

Digital Health Ecosystems and Its Implications for HIV and Other Co-Infections - Sin How Lim

Social Innovations in Health, Especially with Implications for HIV and Other Co-Infections - Beatrice Halpaap

Clinical Implications of Cabotegravir Plasma Levels - Charles Flexner, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

DDIs Relevant for COVID-19 Therapeutic Agents & Implementation Challenges - Fiona Marra, MPharm, MSc

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Emerging Strategies for Treating and Preventing Monkeypox 2022 - Ruth Byrne, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Long-acting Cabotegravir Pharmacokinetics With and Without Oral Lead-in for HIV PrEP - Kelong Han

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

The Non-adherent Patient A Good or Bad Candidate for CAB+RPV - Jose Castillo-Mancilla, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

AntiviralPK22_CabotegravirRilpivirine Failures Despite Adherence Slides_Castillo-Mancilla, Jose

CabotegravirRilpivirine Failures Despite Adherence Slides - Jose Castillo-Mancilla, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Deep Learning Ensemble Classifier to Predict Drug-Drug Interaction - Thao Pham

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Islatravir Toxicity Slides - Charles Flexner, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022